About Fareva
Fareva is a Healthcare company based in Paris (France) founded in 1990. Contract development, manufacturing, and packaging services for pharmaceuticals are provided. Fareva has completed 1 acquisition, including Axess Groupe. Its website fareva.com draws about 15 thousand monthly visits. Fareva offers products and services including Subcontracting Services, Customized Solutions, and Turnkey Products. Its focus areas include Biopharma Outsourcing, CDMO and Diversified. Its legal entity is FAREVA MG, INC.
Company details
Fareva Group was founded in 1990 and is headquartered in Paris, France. Operations are maintained primarily in Europe and the USA within the pharmaceutical sector. Contract development and manufacturing services are offered for finished dosage forms and active pharmaceutical ingredients. Therapeutic areas addressed include anticancer agents, steroids, and antivirals. Manufacturing capabilities cover solid, semi-solid, liquid, injectable, and sterile forms, alongside highly potent APIs, hormones, and related compounds.
- Headquarters Paris, France
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website fareva.com/en
- Social LinkedIn
- Legal Name Fareva Mg, Inc
- Annual Revenue$2.42 M (USD)28as on Dec 31, 2022
- Net Profit$17.08 M (USD)-65as on Dec 31, 2022
- EBITDA$17.39 M (USD)-65as on Dec 31, 2022
- Latest Funding Round$316.61K (USD), Grant
May 2021
- Investors
- Investments & Acquisitions
Products & Services of Fareva
Fareva offers a comprehensive portfolio of products and services, including Subcontracting Services, Customized Solutions, and Turnkey Products.
Outsourced production and packaging for client products
Tailored product development for various sectors
Pre-developed options for quick product launches
Funding Insights of Fareva
- Total Rounds 1
- Last Round Grant — $316,606
- First Round $316,606
(May 2021)
- Investors Count 1
All 1 funding rounds of Fareva with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2021 | $316,606 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Fareva
Fareva has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ministères Aménagement du territoire Transition écologique.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| ecologie.gouv.fr |
Investor details for Fareva
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Fareva
23 people are tracked at Fareva (16 in leadership, 7 in team).
| Name | Role | Group |
|---|---|---|
Gökhan Becerikli | Supply Chain & Global Planning Director - Beauty & Homecare BU | Leadership |
Bernard Fraisse | President&ceo | Leadership |
Thibaut Fraisse | CEO Make-up Division | Leadership |
Christophe Petras | CEO Business Unit Beauty & Homecare | Leadership |
Jean-Cyril Mourier | Vice President Information Systems & Business Solutions | Leadership |
Rodolphe Suicmez | VP Operations Europe | Leadership |
Lucio X | Vice President Operation To Beauty & Homecare At Brazil And México | Leadership |
Arnaud Brilland | VP Sales Americas | Leadership |
Florent Vallet | Vice President Sales & Operations API | Leadership |
Alexandre Bastit | CEO Business Unit Pharma & API | Leadership |
Nicola Mostardini | CFO | Leadership |
Edgard Bazzana | Key Account Director | Leadership |
Volkan Bozdemir | VP Operations Uk, East & Middle East | Leadership |
Charles Stringer Sr. | Financial Director | Leadership |
Joris Grinberg | Marketing Director BU Beauty & Homecare | Leadership |
Christian Darsy | Vice President Sales Cosmetic | Leadership |
Thais Rodrigues | Planejadora Sênior | Team |
Franck Bonnet | Vice-président Opérations Europe | Team |
Andre Furtado | Planning And Control Manager | Team |
Loryn Sweeney | Beauty Supply Chain Manager | Team |
3 more people are available in the full profile.
Complete people profiles for Fareva
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fareva
Fareva has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Axess Groupe.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Pharmaceuticals and beauty products are manufactured by BCM. | bcm-manufacturing.com | United Kingdom | 1992 | Jul 2017 | •••• |
Complete acquisition details for Fareva
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Fareva
3 dated milestones of Fareva across 31 years, from founding to its latest funding, stage changes and deals.
- Founded Fareva is founded.
- Acquisition Acquires Axess Groupe.
- Funding First funding round of $317K.
Web traffic of Fareva
The website of Fareva (fareva.com) receives about 14.6K visits a month and ranks #1,040,773 among all websites worldwide, #1,292 in Biotechnology and Pharmaceuticals.
- Monthly visits14.6K
▼ 29% vs previous month
- Unique visitors9.4K
per month
- Global rank#1,040,773
among all websites
- Category rank#1,292
Health · Biotechnology and Pharmaceuticals
- Bounce rate42%
- Pages per visit3.4
- Average visit19 sec
- DevicesDesktop 40% · Mobile 60%
Websites whose visitors overlap most with Fareva. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| nextpharma.com | 100% | 8K | #1,667,239 | View details | |
| lomapharm.de | 100% | 2K | #5,491,269 | View details | |
| aesica-pharma.com | 100% | View details | |||
ursapharm.de | ursapharm.de | 66% | #780,498 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fareva
Complete news archive for Fareva
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fareva
Fareva was founded in 1990 and raised its 1st funding round 31 years after it was founded.
Fareva is headquartered in Paris, France.
Annual revenue of Fareva is $2.42M as on Dec 31, 2022.
Fareva Group was founded in 1990 and is headquartered in Paris, France. Operations are maintained primarily in Europe and the USA within the pharmaceutical sector. Contract development and manufacturing services are offered for finished dosage forms and active pharmaceutical ingredients. Therapeutic areas addressed include anticancer agents, steroids, and antivirals. Manufacturing capabilities cover solid, semi-solid, liquid, injectable, and sterile forms, alongside highly potent APIs, hormones, and related compounds.
Fareva offers Subcontracting Services, Customized Solutions, and Turnkey Products.
Fareva has made 1 acquisition, including Axess Groupe.
Fareva has 1 investor. Key investors include Ministères Aménagement du territoire Transition écologique.
Fareva operates through Fareva Mg, Inc.